Results for tag: "Frontotemporal Disorders Drug"

Frontotemporal Disorders (FTD) are a group of neurological conditions that affect the frontal and temporal lobes of the brain. These disorders are characterized by changes in behavior, language, and/or movement. FTD is the second most common form of dementia after Alzheimer's disease. FTD is a complex disorder with no known cure. Treatment focuses on managing symptoms and improving quality of life. Medications used to treat FTD include antidepressants, antipsychotics, and cholinesterase inhibitors. These drugs can help reduce symptoms such as depression, aggression, and agitation. The Frontotemporal Disorders Drug market is a rapidly growing segment of the Central Nervous System Drugs market. As the prevalence of FTD increases, so does the demand for effective treatments. Companies in this market are focused on developing new drugs and therapies to improve the lives of those affected by FTD. Some companies in the Frontotemporal Disorders Drug market include AbbVie, Allergan, AstraZeneca, Biogen, Eli Lilly, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more